vs
Side-by-side financial comparison of BADGER METER INC (BMI) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
BADGER METER INC is the larger business by last-quarter revenue ($234.1M vs $205.4M, roughly 1.1× COLLEGIUM PHARMACEUTICAL, INC). BADGER METER INC runs the higher net margin — 14.3% vs 8.3%, a 6.1% gap on every dollar of revenue. On growth, BADGER METER INC posted the faster year-over-year revenue change (14.1% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $50.8M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 9.2%).
Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
BMI vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $234.1M | $205.4M |
| Net Profit | $33.6M | $17.0M |
| Gross Margin | 39.7% | 62.5% |
| Operating Margin | 18.4% | 29.6% |
| Net Margin | 14.3% | 8.3% |
| Revenue YoY | 14.1% | 12.9% |
| Net Profit YoY | 9.3% | 35.3% |
| EPS (diluted) | $1.13 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $234.1M | $205.4M | ||
| Q3 25 | $222.2M | $209.4M | ||
| Q2 25 | $238.1M | $188.0M | ||
| Q1 25 | $222.2M | $177.8M | ||
| Q4 24 | $205.2M | $181.9M | ||
| Q3 24 | $208.4M | $159.3M | ||
| Q2 24 | $216.7M | $145.3M | ||
| Q1 24 | $196.3M | $144.9M |
| Q4 25 | $33.6M | $17.0M | ||
| Q3 25 | $35.1M | $31.5M | ||
| Q2 25 | $34.6M | $12.0M | ||
| Q1 25 | $38.4M | $2.4M | ||
| Q4 24 | $30.7M | $12.5M | ||
| Q3 24 | $32.0M | $9.3M | ||
| Q2 24 | $33.1M | $19.6M | ||
| Q1 24 | $29.1M | $27.7M |
| Q4 25 | 39.7% | 62.5% | ||
| Q3 25 | 43.1% | 61.7% | ||
| Q2 25 | 41.1% | 57.7% | ||
| Q1 25 | 42.9% | 54.8% | ||
| Q4 24 | 40.3% | 54.0% | ||
| Q3 24 | 40.2% | 60.8% | ||
| Q2 24 | 39.4% | 62.5% | ||
| Q1 24 | 39.3% | 63.1% |
| Q4 25 | 18.4% | 29.6% | ||
| Q3 25 | 20.7% | 29.7% | ||
| Q2 25 | 18.8% | 18.7% | ||
| Q1 25 | 22.2% | 12.2% | ||
| Q4 24 | 19.1% | 20.9% | ||
| Q3 24 | 19.5% | 21.9% | ||
| Q2 24 | 19.2% | 32.7% | ||
| Q1 24 | 18.6% | 34.1% |
| Q4 25 | 14.3% | 8.3% | ||
| Q3 25 | 15.8% | 15.0% | ||
| Q2 25 | 14.5% | 6.4% | ||
| Q1 25 | 17.3% | 1.4% | ||
| Q4 24 | 15.0% | 6.9% | ||
| Q3 24 | 15.4% | 5.9% | ||
| Q2 24 | 15.3% | 13.5% | ||
| Q1 24 | 14.8% | 19.1% |
| Q4 25 | $1.13 | $0.48 | ||
| Q3 25 | $1.19 | $0.84 | ||
| Q2 25 | $1.17 | $0.34 | ||
| Q1 25 | $1.30 | $0.07 | ||
| Q4 24 | $1.04 | $0.36 | ||
| Q3 24 | $1.08 | $0.27 | ||
| Q2 24 | $1.12 | $0.52 | ||
| Q1 24 | $0.99 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $386.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $713.3M | $301.7M |
| Total Assets | $973.6M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $386.7M | ||
| Q3 25 | — | $285.9M | ||
| Q2 25 | — | $222.2M | ||
| Q1 25 | — | $197.8M | ||
| Q4 24 | — | $162.8M | ||
| Q3 24 | — | $120.0M | ||
| Q2 24 | — | $271.6M | ||
| Q1 24 | — | $318.0M |
| Q4 25 | $713.3M | $301.7M | ||
| Q3 25 | $702.5M | $274.8M | ||
| Q2 25 | $677.6M | $232.2M | ||
| Q1 25 | $641.7M | $234.4M | ||
| Q4 24 | $606.2M | $228.8M | ||
| Q3 24 | $591.2M | $234.3M | ||
| Q2 24 | $563.1M | $216.6M | ||
| Q1 24 | $535.6M | $222.2M |
| Q4 25 | $973.6M | $1.7B | ||
| Q3 25 | $978.3M | $1.6B | ||
| Q2 25 | $936.4M | $1.6B | ||
| Q1 25 | $899.6M | $1.6B | ||
| Q4 24 | $816.4M | $1.7B | ||
| Q3 24 | $802.9M | $1.6B | ||
| Q2 24 | $781.3M | $1.1B | ||
| Q1 24 | $743.5M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $54.8M | $123.0M |
| Free Cash FlowOCF − Capex | $50.8M | $122.4M |
| FCF MarginFCF / Revenue | 21.7% | 59.6% |
| Capex IntensityCapex / Revenue | 1.7% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.63× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $169.7M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.8M | $123.0M | ||
| Q3 25 | $51.3M | $78.4M | ||
| Q2 25 | $44.6M | $72.4M | ||
| Q1 25 | $33.0M | $55.4M | ||
| Q4 24 | $52.1M | $84.6M | ||
| Q3 24 | $45.1M | $-9.0M | ||
| Q2 24 | $36.4M | $67.4M | ||
| Q1 24 | $21.5M | $61.9M |
| Q4 25 | $50.8M | $122.4M | ||
| Q3 25 | $48.2M | $78.3M | ||
| Q2 25 | $40.6M | $72.4M | ||
| Q1 25 | $30.1M | $54.6M | ||
| Q4 24 | $47.4M | $84.1M | ||
| Q3 24 | $42.0M | $-9.2M | ||
| Q2 24 | $34.1M | $67.1M | ||
| Q1 24 | $18.8M | $61.4M |
| Q4 25 | 21.7% | 59.6% | ||
| Q3 25 | 21.7% | 37.4% | ||
| Q2 25 | 17.1% | 38.5% | ||
| Q1 25 | 13.5% | 30.7% | ||
| Q4 24 | 23.1% | 46.2% | ||
| Q3 24 | 20.1% | -5.8% | ||
| Q2 24 | 15.7% | 46.2% | ||
| Q1 24 | 9.6% | 42.3% |
| Q4 25 | 1.7% | 0.3% | ||
| Q3 25 | 1.4% | 0.1% | ||
| Q2 25 | 1.7% | 0.0% | ||
| Q1 25 | 1.3% | 0.4% | ||
| Q4 24 | 2.3% | 0.3% | ||
| Q3 24 | 1.5% | 0.2% | ||
| Q2 24 | 1.1% | 0.2% | ||
| Q1 24 | 1.4% | 0.4% |
| Q4 25 | 1.63× | 7.25× | ||
| Q3 25 | 1.46× | 2.49× | ||
| Q2 25 | 1.29× | 6.05× | ||
| Q1 25 | 0.86× | 22.92× | ||
| Q4 24 | 1.70× | 6.75× | ||
| Q3 24 | 1.41× | -0.96× | ||
| Q2 24 | 1.10× | 3.44× | ||
| Q1 24 | 0.74× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BMI
| Transferred At Point In Time | $198.6M | 85% |
| Transferred Over Time | $22.1M | 9% |
| Other | $13.4M | 6% |
COLL
Segment breakdown not available.
